CHIR Expert Testifies Before the House Committee on Small Business Regarding Enhancements to the ACA

On February 7, the House Committee on Small Business held a hearing titled, “Reimagining the Health Care Marketplace for America’s Small Businesses,” to discuss the challenges small businesses are facing in the health insurance marketplaces and to offer potential solutions for the next phase of reform. Georgetown’s own Dania Palanker provided testimony on how the ACA has helped to lessen the burdens for small business owners who wish to provide health coverage to employees. Continue reading

Policy Experts Talk Strategies, Obstacles for “Repeal and Replace”

The Affordable Care Act (ACA) has increased access to health care by expanding coverage and reducing the number of uninsured, but problems facing consumers and insurers have some calling for repealing, replacing, or repairing the law. It seems every day we are presented with a new replacement plan or proposed rule, leaving the future of the health care landscape uncertain. Recently, CHIR sent Rachel Schwab to cover two D.C. events that brought together health policy experts to discuss the options and obstacles in front of us. Continue reading

Risky Business: Health Actuaries Assess the Individual Market and Rates

As the health care debate continues, we face a number of unknowns. Congressional leadership and President Trump vowed to repeal the ACA, but have yet to reach a consensus on the replacement plan. Meanwhile, consumers and insurers are making big decisions about health plans without knowing what the individual market will look like. Predicting the impact of unknown events is no easy task; if you’ve misplaced your crystal ball, the American Academy of Actuaries (AAA) recently released an issue paper on the future of the individual market, lending their expertise to a debate riddled with uncertainty. Continue reading

Repealing The ACA Could Worsen The Opioid Epidemic

As our country grapples with an “unprecedented opioid epidemic,” Congress is taking steps to take away an important tool to fight it — the Affordable Care Act (ACA). In a post for the Health Affairs blog, CHIR expert Dania Palanker and Urban Institute researchers Lisa Clemans-Cope and Jane Wishner assess policies and programs under the ACA that have helped tackle the opioid crisis and what could be lost if they are repealed. Continue reading

Promising Steps to Strengthen Marketplace Risk Pools Could be in Vain, if Affordable Care Act is Repealed

While critics have been describing the demise of the marketplaces established by the Affordable Care Act, the Obama Administration has been taking steps to strengthen the risk pool and to ensure its long-term sustainability. These promising steps are now at risk under the threat of repeal with nothing to replace approach that Congressional leaders and the new administration seem to be taking. At risk and in jeopardy is the coverage of millions of people. CHIR’s Sandy Ahn takes a look. Continue reading

Busting the “Falling under its Own Weight” Myth: New Analysis Shows Better Outlook for the Affordable Care Act Marketplaces

It’s a new year, and with it comes new hope for the Affordable Care Act’s (ACA) exchanges. Wall Street analysts recently released research that shows improvements in insurers’ finances for 2016, predicting even better margins for future years. But just as the markets are starting to stabilize, the incoming Congress and Administration are threatening to undo them. Continue reading

Tick Tock: An Unforgiving Calendar for Health Plans Makes Orderly “Transition” for Affordable Care Act Repeal Unlikely

The incoming Congress and Administration have pledged to repeal the Affordable Care Act but hope to minimize disruption by providing for a transition period. However, insurers must make key decisions about health plans and pricing far in advance of bringing those plans to market. In an ongoing series of articles for The Commonwealth Fund, CHIR experts Sabrina Corlette and Kevin Lucia partner with Julie Andrews of Wakely Consulting Group to examine how the uncertainty created by Congressional action could result in far fewer plan choices and significantly higher premiums for consumers. Continue reading